Author
Share this page:
Tag Archives: Cirrhosis
What is the Best Way to Care for Patients with Alcoholic Hepatitis?
Although alcohol-related liver disease is the 8th most common cause of mortality in the US and the 2nd leading cause of mortality among all gastrointestinal diseases, there are few therapeutic options for patients or resources to support identification of new … Continue reading
Posted in Liver/Biliary
Tagged alcohol, alcoholic, Cirrhosis, damage, drugs, ethanol, Fibrosis, hepatocyte, immune response, Inflammation, Kupfer cell, liver disease, therapy, treatment
1 Comment
Are Patients Receiving the Latest Anti-HCV Drugs?
Less than 20% of patients infected with the most common Hepatitis C virus (HCV) genotype receive the latest drugs approved by the US Food and Drug Administration (FDA), according to the August issue of Clinical Gastroenterology and Hepatology. This low … Continue reading
Posted in Liver/Biliary, Technology
Tagged Cirrhosis, clinical tirial, DAA, direct-acting anti-viral agent, drug, Fibrosis, HCV, hepatitis, liver, patient management, therapy, treatment, virus
2 Comments
What are the Effects of Albumin in Patients With SBP?
Albumin infusion prevents renal impairment and reduces mortality among patients with spontaneous bacterial peritonitis (SBP), according to a meta-analysis published in the February issue of Clinical Gastroenterology and Hepatology. SBP is a common bacterial infection among cirrhotic patients and a … Continue reading
Posted in Liver/Biliary
Tagged ascites, bacterial infection, blood volume, Cirrhosis, complication, hepatitis, immune response, Inflammation, kidney, liver disease, nephrology, therapy, treatment
2 Comments
New Ways to Study HCV, Genotypes 3 and 4
Researchers can now study replication of Hepatitis C virus genotypes 3 and 4 in cultured cells, described in 2 articles in the January issue of Gastroenterology. These new tools will improve our understanding of how they cause liver disease, and … Continue reading
Posted in Liver/Biliary, Technology
Tagged antiviral, assay, Cirrhosis, DAA, drug testing, experimental system, HCV, hepatitis C virus, in vitro, laboratory, liver disease, model, replication
2 Comments
Can We Prevent Portal Vein Thrombosis in Patients With Cirrhosis?
The anti-clotting agent enoxaparin prevents portal vein thrombosis (PVT) in patients with cirrhosis, according to the November issue of Gastroenterology. PVT can lead to portal hypertension and reduce the blood supply to the liver—some patients with acute or extensive PVT develop severe gastrointestinal … Continue reading
Differences in HCV Infection, and Effects of Treatment, Among Countries
Hepatitis C virus (HCV) infections have developed and spread at different rates in different countries, affecting outcomes of therapy, according to the October issue of Gastroenterology. Specific details of each population must therefore be considered in designing prevention and treatment … Continue reading
Posted in Liver/Biliary
Tagged Cirrhosis, disease progression, Epidemiology, Europe, Fibrosis, hepatitis, Liver Cancer, liver disease, transplant, United States
Leave a comment
How Common is Portal Hypertension in Patients With NAFLD?
Patients with nonalcoholic fatty liver disease (NAFLD) are at risk for portal hypertension and esophageal varices, according to the September issue of Clinical Gastroenterology and Hepatology. The study also shows that factors such as advanced liver disease, type 2 diabetes, … Continue reading
Posted in GI Tract, Liver/Biliary
Tagged Cirrhosis, disease progression, fatty liver disease, Fibrosis, Inflammation, liver disease, NAFLD, NASH, Obesity, Prevention, risk factor
5 Comments
It’s Not Easy to Diagnose Intermediate-Stage Liver Fibrosis
Biopsy has a low level of diagnostic performance for liver fibrosis stages F2 and F1. The recommendation for biopsy analysis, instead of non-invasive tests, for diagnosis of intermediate stages of fibrosis is therefore misleading, according to the June issue of … Continue reading
Posted in Liver/Biliary, Technology
Tagged Cirrhosis, diagnostic, HBV, HCV, hepatitis progression, Inflammation, liver disease, pathology anlysis, prognostis, response to therapy, testing
1 Comment
A Special Issue on Viral Hepatitis
The May issue of Gastroenterology features a very special supplement—“Viral Hepatitis: A Changing Field”—comprising 17 review and commentary articles from international leaders in hepatitis treatment and research. The issue provides insight into the rapid progress made in the treatment and … Continue reading
Posted in Cancer, Liver/Biliary, Technology
Tagged Cirrhosis, editorial, HAV, HBV, HCV, hepatitis, HEV, perspective, review, therapy, treatment, Virology
2 Comments
Is Cardiac Surgery Safe for Patients With Cirrhosis?
Patients with compensated cirrhosis who undergo cardiac surgery with cardiopulmonary bypass do not have greater post-operative mortality or morbidity than other patients who receive this surgery, according to the May issue of Clinical Gastroenterology and Hepatology. Advanced liver disease is … Continue reading
Posted in GI Tract, Technology
Tagged ascites, cardiac surgery, Cirrhosis, Complications, heart surgery, hepatic decompensation, liver disease, risk factors, safety, therapy, treatment
3 Comments
Kristine Novak, PhD, Science Editor
agajournals.wordpress.com 